BROWSE·page 43 of 257

Browse EX-10 agreements

3,074 matching material contract exhibits.


EX-10.9

AUDIOEYE INC

​

Exhibit 10.9

​

AUDIOEYE, INC.

2020 EQUITY INCENTIVE PLAN

​

Restricted Stock Unit Agreement

(Non-Employee Director Annual Awards)

​

AudioEye, Inc. (the “Company”), pursuant to its 2020 Equity Incentive Plan (the “Plan”), hereby grants an award of Restricted Stock Units to you, the Participant named below.  The terms and conditions of this Award are set forth in this Restricted Stock Unit Award Agreement (the “Agreement”), consisting of this cover page and the Terms and Conditions on the following pages, and in the Plan document, a copy of which has been provided to you.  Any capitalized term that is used but not defined in this Agreement shall have the meaning assigned to it in the Plan as it currently exists or as it is amended in the future.

…

EX-10.9·10-Q·CIK 1362190·ACC 0001104659-26-096032·Filed Aug 13, 2026, 17:11 ET

EX-10.10

AUDIOEYE INC

​

Exhibit 10.10

​

AUDIOEYE, INC.

2020 EQUITY INCENTIVE PLAN

​

Performance Stock Unit Agreement

​

AudioEye, Inc. (the “Company”), pursuant to its 2020 Equity Incentive Plan (the “Plan”), hereby grants an award of Performance Stock Units to you, the Participant named below.  The terms and conditions of this Award are set forth in this Performance Stock Unit Agreement (the “Agreement”), consisting of this cover page, the Terms and Conditions on the following pages and the attached Exhibit A, and in the Plan document, a copy of which has been provided to you.  Any capitalized term that is used but not defined in this Agreement shall have the meaning assigned to it in the Plan as it currently exists or as it is amended in the future.

​

…

EX-10.10·10-Q·CIK 1362190·ACC 0001104659-26-096032·Filed Aug 13, 2026, 17:11 ET

EX-10.5

AUDIOEYE INC

​

AUDIOEYE, INC.

2020 EQUITY INCENTIVE PLAN

​

Performance Stock Unit Agreement

​

AudioEye, Inc. (the “Company”), pursuant to its 2020 Equity Incentive Plan (the “Plan”), hereby grants an award of Performance Stock Units to you, the Participant named below.  The terms and conditions of this Award are set forth in this Performance Stock Unit Agreement (the “Agreement”), consisting of this cover page, the Terms and Conditions on the following pages and the attached Exhibit A, and in the Plan document, a copy of which has been provided to you.  Any capitalized term that is used but not defined in this Agreement shall have the meaning assigned to it in the Plan as it currently exists or as it is amended in the future.

​

…

EX-10.5·10-Q·CIK 1362190·ACC 0001104659-26-096032·Filed Aug 13, 2026, 17:11 ET

EX-10.1

Intuitive Machines, Inc.

INTUITIVE MACHINES, LLC SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT Dated as of February 13, 2023 THE LIMITED LIABILITY COMPANY INTERESTS REPRESENTED BY THIS SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR UNDER ANY OTHER APPLICABLE SECURITIES LAWS. SUCH LIMITED LIABILITY COMPANY INTERESTS MAY NOT BE SOLD, ASSIGNED, PLEDGED OR OTHERWISE DISPOSED OF AT ANY TIME WITHOUT EFFECTIVE REGISTRATION UNDER SUCH ACT AND LAWS OR EXEMPTION THEREFROM, AND COMPLIANCE WITH THE OTHER SUBSTANTIAL RESTRICTIONS ON TRANSFERABILITY SET FORTH HEREIN. Exhibit 10.1


…

EX-10.1·10-Q·CIK 1844452·ACC 0001628280-26-056821·Filed Aug 13, 2026, 17:09 ET

EX-10.1

Sculptor Diversified Real Estate Income Trust, Inc.

AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT

OF

MIH MEMBER LLC

This AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT

(together with the schedule attached hereto, this “Agreement”) of MIH Member LLC, a Delaware limited liability company (the “Company”), is made and entered into as of May 1, 2026, by and among the persons and entities listed as members of the Company on Schedule A hereto (as such schedule is supplemented or amended from time to time) (such persons and entities and any substitute or additional member being referred to herein each as a “Member” and collectively as the “Members”), Sculptor Real Estate Parallel Fund V D Co-Investments, LP, a Delaware limited partnership, and Sculptor Real Estate Fund V C Co-Investments, LP, a Delaware limited partnership (each, a “New Member” and collectively, the “New Members”), and Sculptor Real Estate MI Fund, LP, a Delaware limited partnership (the “MI Fund”), as the Managing Member (as defined herein).

R E C I T A L S:

…

EX-10.1·10-Q·CIK 1914496·ACC 0001914496-26-000135·Filed Aug 13, 2026, 17:06 ET

EX-10.2

Sculptor Diversified Real Estate Income Trust, Inc.

LOAN AGREEMENT Dated as of May 1, 2026 By and Among MIH PROPCO LLC, MIH ROOKERY LLC, and MIH HAMMOCK BAY LLC, each a Delaware limited liability company, collectively, as Borrower, MIH OPCO LLC, a Delaware limited liability company, as Operating Lessee and WELLS FARGO BANK, NATIONAL ASSOCIATION and JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, collectively, as Lender Exhibit 10.2


i TABLE OF CONTENTS Page ARTICLE I – DEFINITIONS; PRINCIPLES OF CONSTRUCTION. ........................................ 1 Section 1.1 Definitions.................................................................................................. 1 Section 1.2 Principles of Construction........................................................................ 55 ARTICLE II ................................................................................................................................. 55 ARTICLE II - GENERAL TERMS ............................................................................................. 55 Section 2.1 Loan Commitment; Disbursement to Borrower

…

EX-10.2·10-Q·CIK 1914496·ACC 0001914496-26-000135·Filed Aug 13, 2026, 17:06 ET

EX-10.2

REALLOYS INC.

Certain personal identifying information has been excluded from this exhibit pursuant to Item 601(a)(6) of Regulation S-K. Redacted information is indicated by [***]. REALLOYS INC. Chief Financial Officer Consulting Agreement Between REalloys Inc. and Provenance Advisors Effective Date: June 24, 2026


REalloys Inc. Chief Financial Officer Consulting Agreement This Chief Financial Officer Consulting Agreement is entered into as of June 24, 2026 by and between REalloys Inc., a Nevada corporation listed on NASDAQ under the symbol ALOY, and Provenance Advisors Inc. (the “Consultant”). REalloys Inc. and its subsidiaries are referred to collectively as the “Company.” The Company desires to retain the Consultant to provide services as the Company's Chief Financial Officer on an independent contractor basis, and the Consultant desires to provide those services on the terms set forth in this Agreement. Accordingly, the parties agree as follows. 1. Engagement and Appointment 1.1 Appointment The Company hereby retains the Consultant to provide

…

EX-10.2·10-Q·CIK 1567900·ACC 0001628280-26-056817·Filed Aug 13, 2026, 17:05 ET

EX-10.3

REALLOYS INC.

Certain personal identifying information has been excluded from this exhibit pursuant to Item 601(a)(6) of Regulation S-K. Redacted information is indicated by [***]. EMPLOYMENT AGREEMENT This Employment Agreement ("Agreement") is entered into as of 10 August 2026, between: Employer: REalloys Canada Inc., a corporation incorporated under the laws of Canada and a wholly-owned subsidiary of REalloys Inc. (NASDAQ: ALOY) (the "Company") — and — Employee: Muhammad Imran, residing at [***] ("Employee") The Company and the Employee are referred to individually as a "Party" and collectively as the "Parties". In consideration of the mutual covenants set out in this Agreement, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged), the Parties agree as follows. Schedule B (Summary of Compensation Terms) is attached hereto, incorporated by reference, and forms part of this Agreement. 1. POSITION The Company agrees to employ the Employee as "Chief Operating Officer" of REalloys Inc. and its consolidated subsidiaries and operations ("COO") co

…

EX-10.3·10-Q·CIK 1567900·ACC 0001628280-26-056817·Filed Aug 13, 2026, 17:05 ET

EXHIBIT 10.25

Z Squared Inc.

Contribution Agreement

This Contribution Agreement (this “Agreement”), dated and effective as of April 15, 2026 (the “Effective Date”), is by and between Coeptis Therapeutics Holdings Inc., a Delaware corporation (the “Company”), and Coeptis Holdings, Inc., a Delaware corporation ( “Spin Out Sub”).

WHEREAS, the Company is a biopharmaceutical company which owns, acquires, and develops innovative cell therapy platforms for cancer, autoimmune, and infectious diseases;

WHEREAS, Spin Out Sub, in connection with the transactions contemplated hereby, will become a wholly-owned subsidiary of the Company; and

WHEREAS, the Company and Spin Out Sub desire to enter into this Agreement pursuant to which the Company will (i) convey to Spin Out Sub certain equity securities held by the Company, as a capital contribution to Spin Out Sub and (ii) become the sole stockholder of Spin Out Sub, on the terms and subject to the conditions set forth in this Agreement (the “Contribution”).

…

EX-10.25·10-Q·CIK 1759186·ACC 0001185185-26-003508·Filed Aug 13, 2026, 17:01 ET

EXHIBIT 10.27

Z Squared Inc.

OPTION AGREEMENT

(GEAR Therapeutics Inc.)

This OPTION AGREEMENT (“Agreement”) is made and entered into as of April 24 , 2026 (the “Effective Date”), by and between Coeptis Therapeutics Holdings, Inc., a Delaware corporation (“Seller”), and Coeptis Holdings, Inc., a Delaware corporation (including its designee(s), “Option Holder”). GEAR Therapeutics, Inc., a Florida corporation (“Company”) is also a party to this Agreement.

** **

WHEREAS, Seller is currently the sole owner of 8,300,00 shares of the Company’s Class A Voting Common Stock, which Class A Voting Common Stock represent 100% of the issued and outstanding shares of Class A Voting Common Stock and 83% of the issued and outstanding ownership interests of the Company (such shares of Class A Voting Common Stock, the “Seller Interests”);

** **

WHEREAS, Seller wishes to grant to Option Holder, and Option Holder wishes to accept from Seller, on the terms and subject to the conditions set forth in this Agreement, an option to purchase the Seller Interests.

…

EX-10.27·10-Q·CIK 1759186·ACC 0001185185-26-003508·Filed Aug 13, 2026, 17:01 ET

EXHIBIT 10.26

Z Squared Inc.

** **

Assignment and Assumption Agreement

This Assignment and Assumption Agreement (this “Agreement”), dated and effective as of April 15, 2026 (the “Effective Date”), is by and between Coeptis Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), and Coeptis Therapeutics, Inc., a Delaware corporation (“Subsidiary”).

** **

WHEREAS, the Company is a biopharmaceutical company which owns, acquires, and develops innovative cell therapy platforms for cancer, autoimmune, and infectious diseases;

** **

WHEREAS, Subsidiary is a wholly-owned subsidiary of the Company; and

** **

WHEREAS, the Company and Subsidiary desire to enter into this Agreement pursuant to which the Company will convey certain of its biopharmaceutical operations assets and liabilities to Subsidiary and Subsidiary will accept such conveyance (the “Assignment”).

** **

…

EX-10.26·10-Q·CIK 1759186·ACC 0001185185-26-003508·Filed Aug 13, 2026, 17:01 ET

EX-10.1

MapLight Therapeutics, Inc.

RELEASE AGREEMENT

My employment with MapLight Therapeutics, Inc. (the “Company”) terminated on June 18, 2026 (the “Separation Date”). I confirm that I have been paid all compensation owed to me for all hours worked for the Company through the Separation Date; I received all the leave and leave benefits and protections for which I was eligible during my employment; and I have not suffered any on-the-job injury for which I have not already filed a claim.

I represent that I have returned all Company equipment, property and documents and any other embodiments of the Company’s proprietary or confidential information (and all reproductions thereof, in whole or in part) (“Company Property”) previously in my possession or control. I acknowledge and agree to continue to abide by my continuing obligations under my Employee Confidential Information, Inventions, Non-Solicitation and Non-Competition Agreement.

…

EX-10.1·10-Q·CIK 1770069·ACC 0001193125-26-349554·Filed Aug 13, 2026, 17:01 ET